SacI RFLP in the insulin-like growth factor 2 receptor gene (IGF2R) on human chromosome 6q

Por Hauptschein, R., Dalla-Favera, R., Gaidano, G.
Publicado em 1991

Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity.

Por Gaidano, G., Carbone, A., Dalla-Favera, R.
Publicado em 1998

KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Report of two cases with anaplastic large cell morphology and plasmablastic immunophenotype

Por Carbone, A, Gloghini, A, Vaccher, E, Marchetti, G, Gaidano, G, Tirelli, U
Publicado em 2005

A new Taql polymorphism in the p53 gene

Por Serra, A., Gaidano, G.L., Revello, D., Guerrasio, A., Ballerini, P., Favera, R.Dalla, Saglio, G.
Publicado em 1992

BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression.

Por Carbone, A., Gaidano, G., Gloghini, A., Pastore, C., Saglio, G., Tirelli, U., Dalla-Favera, R., Falini, B.
Publicado em 1997

Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia.

Por Gaidano, G., Newcomb, E. W., Gong, J. Z., Tassi, V., Neri, A., Cortelezzi, A., Calori, R., Baldini, L., Dalla-Favera, R.
Publicado em 1994

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

Por Gaidano, G, Ballerini, P, Gong, J Z, Inghirami, G, Neri, A, Newcomb, E W, Magrath, I T, Knowles, D M, Dalla-Favera, R
Publicado em 1991

Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics

Por Pileri, S A, Sabattini, E, Rosito, P, Zinzani, P L, Ascani, S, Fraternali-Orcioni, G, Gamberi, B, Piccioli, M, Vivenza, D, Falini, B, Gaidano, G
Publicado em 2002

Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results

Por Stefoni, V, Casadei, B, Bottelli, C, Gaidano, G, Ciochetto, C, Cabras, M G, Ansuinelli, M, Argnani, L, Broccoli, A, Gandolfi, L, Pellegrini, C, Zinzani, P L
Publicado no Blood Cancer J (2016)

Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option

Por Ripellino, P, Comi, C, Mula, M, Varrasi, C, Conconi, A, Stecco, A, Brustia, D, Nasuelli, N, Savio, K, De Paoli, L, Cantello, R, Gaidano, G, Monaco, F
Publicado em 2011

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma

Por Jurczak, W, Zinzani, P L, Gaidano, G, Goy, A, Provencio, M, Nagy, Z, Robak, T, Maddocks, K, Buske, C, Ambarkhane, S, Winderlich, M, Dirnberger-Hertweck, M, Korolkiewicz, R, Blum, K A
Publicado no Ann Oncol (2018)

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation

Por Malcikova, J., Tausch, E., Rossi, D., Sutton, L. A., Soussi, T., Zenz, T., Kater, A. P., Niemann, C. U., Gonzalez, D., Davi, F., Gonzalez Diaz, M., Moreno, C., Gaidano, G., Stamatopoulos, K., Rosenquist, R., Stilgenbauer, S., Ghia, P., Pospisilova, S.
Publicado no Leukemia (2018)

The genome of chemorefractory chronic lymphocytic leukemia reveals frequent mutations of NOTCH1 and SF3B1

Por Rossi, D, Rasi, S, Spina, V, Bruscaggin, A, Monti, S, Cresta, S, Famà, R, Deambrogi, C, Greco, M, Fangazio, M, Ciardullo, C, Piranda, D, Casaluci, G M, Messina, M, Giudice, I D, Chiaretti, S, Marinelli, M, Guarini, A, Foà, R, Gaidano, G
Publicado no Leukemia Suppl (2012)

319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection

Por Dettorre, G., Diamantis, N., Loizidou, A., Piccart, M., Chester, J., Jackson, A., Tovazzi, V., Fotia, V., Sita-Lumsden, A., Bower, M., Gaidano, G., Felip, E., Ottaviani, D., Sng, C., Rimassa, L., Santoro, A., Aguilar-Company, J., Seguí, E., Dolly, S., Pinato, D.
Publicado no Ann Oncol (2020)

Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study

Por Moreau, P, Joshua, D, Chng, W-J, Palumbo, A, Goldschmidt, H, Hájek, R, Facon, T, Ludwig, H, Pour, L, Niesvizky, R, Oriol, A, Rosiñol, L, Suvorov, A, Gaidano, G, Pika, T, Weisel, K, Goranova-Marinova, V, Gillenwater, H H, Mohamed, N, Aggarwal, S, Feng, S, Dimopoulos, M A
Publicado no Leukemia (2017)

Carfilzomib–dexamethasone vs bortezomib–dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR

Por Chng, W-J, Goldschmidt, H, Dimopoulos, M A, Moreau, P, Joshua, D, Palumbo, A, Facon, T, Ludwig, H, Pour, L, Niesvizky, R, Oriol, A, Rosiñol, L, Suvorov, A, Gaidano, G, Pika, T, Weisel, K, Goranova-Marinova, V, Gillenwater, H H, Mohamed, N, Feng, S, Aggarwal, S, Hájek, R
Publicado no Leukemia (2017)

Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile

Por Giudice, I Del, Rigolin, GM, Raponi, S, Cafforio, L, Ilari, C, Wang, J, Bordyuh, M, Piciocchi, A, Marinelli, M, Nanni, M, Tavolaro, S, Filetti, M, Bardi, A, Tammiso, E, Volta, E, Negrini, M, Saccenti, E, Mauro, FR, Rossi, D, Gaidano, G, Guarini, A, Rabadan, R, Cuneo, A, Foà, R
Publicado no Leukemia (2017)

1679P Determinants of mortality from SARS-CoV-2 infection in European cancer patients

Por Pinato, D.J., Sng, C., Wong, Y.N.S., Biello, F., Seguí, E., Aguilar-Company, J., Carbo Bague, A., Patriarca, A., Bower, M.D., Rizzo, G., Bruna, R., Cruz, C.A., D'Avanzo, F., Newsom-Davis, T., Mollà, M., Gaidano, G., Brunet, J., Tabernero, J., Prat, A., Gennari, A.
Publicado no Ann Oncol (2020)

Genetic landscape of ultra-stable chronic lymphocytic leukemia patients

Por Raponi, S, Del Giudice, I, Marinelli, M, Wang, J, Cafforio, L, Ilari, C, Piciocchi, A, Messina, M, Bonina, S, Tavolaro, S, Bordyuh, M, Mariglia, P, Peragine, N, Mauro, F R, Chiaretti, S, Molica, S, Gentile, M, Visentin, A, Trentin, L, Rigolin, G M, Cuneo, A, Diop, F, Rossi, D, Gaidano, G, Guarini, A, Rabadan, R, Foà, R
Publicado no Ann Oncol (2018)

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

Por Castellino, A., Chiappella, A., LaPlant, B. R., Pederson, L. D., Gaidano, G., Macon, W. R., Inghirami, G., Reeder, C. B., Tucci, A., King, R. L., Congiu, A., Foran, J. M., Pavone, V., Rivera, C. E., Spina, M., Ansell, S. M., Cavallo, F., Molinari, A. L., Ciccone, Giovannino, Habermann, T. M., Witzig, T. E., Vitolo, U., Nowakowski, G. S.
Publicado no Blood Cancer J (2018)